World's Best Scientists 2026 revealed!
Award Badge
Best Female Scientists
2025

D-Index & Metrics

Best Female Scientists

D-Index
131
Citations
79138
World Ranking
333
National Ranking
204

Medicine

D-Index
134
Citations
81961
World Ranking
2121
National Ranking
1198

Julie M. Vose publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Julie M. Vose sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 834 publications — 89th percentile

89% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Julie M. Vose D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Julie M. Vose sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 134 D-Index — 90th percentile

90% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Research.com Recognitions

  • 2025 - Research.com Best Female Scientists Award

Overview

Julie M. Vose is affiliated with the University of Nebraska Medical Center in the United States. Their research primarily spans the field of Medicine, with specific focus areas including Pathology and Forensic Medicine, Oncology, Genetics, Immunology, and Hematology.

Their work covers a range of topics related to lymphoid neoplasms and hematologic malignancies. Key topics in their research include:

  • Lymphoma Diagnosis and Treatment
  • CAR-T cell therapy research
  • Chronic Lymphocytic Leukemia Research
  • Viral-associated cancers and disorders
  • T-cell and Retrovirus Studies
  • Cutaneous lymphoproliferative disorders research
  • CNS Lymphoma Diagnosis and Treatment

Julie M. Vose has contributed extensively to the following publication venues:

  • Blood
  • Clinical Lymphoma Myeloma & Leukemia
  • Journal of Clinical Oncology
  • ONCOLOGY
  • Blood Advances

Their recent scholarly papers include:

  • The International Consensus Classification of Mature Lymphoid Neoplasms: a report from the Clinical Advisory Committee, 2022, Blood
  • Standard-of-Care Axicabtagene Ciloleucel for Relapsed or Refractory Large B-Cell Lymphoma: Results From the US Lymphoma CAR T Consortium, 2020, Journal of Clinical Oncology
  • Brentuximab vedotin in combination with nivolumab in relapsed or refractory Hodgkin lymphoma: 3-year study results, 2021, Blood
  • Prophylactic corticosteroid use in patients receiving axicabtagene ciloleucel for large B-cell lymphoma, 2021, British Journal of Haematology
  • NCCN Guidelines® Insights: B-Cell Lymphomas, Version 5.2021, 2021, Journal of the National Comprehensive Cancer Network

Frequent collaborators in their research include:

  • Matthew A. Lunning
  • Ranjana H. Advani
  • André Goy
  • Umar Farooq
  • Abhinav Deol

Their work demonstrates a sustained engagement with lymphoma and hematologic oncology, reflected in contributions to topics such as CAR-T cell therapy and lymphoma classification. The research collectively spans clinical and translational studies, including consensus classification reports, clinical trial results, prophylactic treatment evaluations, and clinical guidelines insights.

Best Publications

  • Revised response criteria for malignant lymphoma

    Bruce D. Cheson;Beate Pfistner;Malik E. Juweid;Randy D. Gascoyne

  • The Use of Molecular Profiling to Predict Survival after Chemotherapy for Diffuse Large-B-Cell Lymphoma

    Andreas Rosenwald;George Wright;Wing C. Chan;Wing C. Chan;Joseph M. Connors

  • Report of an International Workshop to Standardize Response Criteria for Non-Hodgkin's Lymphomas

    B D Cheson;S J Horning;B Coiffier;M A Shipp

  • International peripheral T-cell and natural killer/T-cell lymphoma study: pathology findings and clinical outcomes.

    Julie M. Vose;M. Neumann;Mildred E. Harris

  • Stromal gene signatures in large-B-cell lymphomas

    G Lenz;G Wright;S S Dave;W Xiao

  • Prediction of survival in follicular lymphoma based on molecular features of tumor-infiltrating immune cells

    Sandeep S. Dave;George Wright;Bruce Tan;Andreas Rosenwald;Andreas Rosenwald

  • Molecular Diagnosis of Primary Mediastinal B Cell Lymphoma Identifies a Clinically Favorable Subgroup of Diffuse Large B Cell Lymphoma Related to Hodgkin Lymphoma

    Andreas Rosenwald;George Wright;Karen Leroy;Xin-You Yu

  • Targeting B cell receptor signaling with ibrutinib in diffuse large B cell lymphoma

    Wyndham H. Wilson;Ryan M. Young;Roland Schmitz;Yandan Yang

  • ALK - anaplastic large-cell lymphoma is clinically and immunophenotypically different from both ALK + ALCL and peripheral T-cell lymphoma, not otherwise specified: Report from the International Peripheral T-Cell Lymphoma Project

    Kerry J. Savage;Nancy Lee Harris;Julie Marie Vose;Fred Ullrich

  • The proliferation gene expression signature is a quantitative integrator of oncogenic events that predicts survival in mantle cell lymphoma

    Andreas Rosenwald;George Wright;Adrian Wiestner;Wing C. Chan;Wing C. Chan

  • Progressive multifocal leukoencephalopathy after rituximab therapy in HIV-negative patients: a report of 57 cases from the Research on Adverse Drug Events and Reports project.

    Kenneth R. Carson;Andrew M. Evens;Elizabeth A. Richey;Thomas M. Habermann

  • Molecular diagnosis of Burkitt's lymphoma.

    Sandeep S. Dave;Kai Fu;George W. Wright;Lloyd T. Lam

  • Inhibition of Syk with fostamatinib disodium has significant clinical activity in non-Hodgkin lymphoma and chronic lymphocytic leukemia

    Jonathan W. Friedberg;Jeff Sharman;John Sweetenham;Patrick B. Johnston

  • Clinical differences between nasal and extranasal natural killer/T-cell lymphoma: a study of 136 cases from the International Peripheral T-Cell Lymphoma Project

    Wing Yan Au;Dennis D. Weisenburger;Tanin Intragumtornchai;Shigeo Nakamura

  • A New Immunostain Algorithm Classifies Diffuse Large B-Cell Lymphoma into Molecular Subtypes with High Accuracy

    William W L Choi;Dennis D. Weisenburger;Timothy Charles Greiner;Miguel A. Piris

  • Prognostic significance of anaplastic lymphoma kinase (ALK) protein expression in adults with anaplastic large cell lymphoma

    Randy D. Gascoyne;Patricia Aoun;Patricia Aoun;Patricia Aoun;Daniel Wu;Daniel Wu;Daniel Wu;Mukesh Chhanabhai;Mukesh Chhanabhai;Mukesh Chhanabhai

  • Pivotal study of iodine I 131 tositumomab for chemotherapy-refractory low-grade or transformed low-grade B-cell non-Hodgkin's lymphomas

    M. S. Kaminski;A. D. Zelenetz;O. W. Press;M. Saleh

  • Updating the American Society of Clinical Oncology Value Framework: Revisions and Reflections in Response to Comments Received

    Lowell E. Schnipper;Nancy E. Davidson;Dana S. Wollins;Douglas W. Blayney

  • Phase II Study of Rituximab in Combination With CHOP Chemotherapy in Patients With Previously Untreated, Aggressive Non-Hodgkin’s Lymphoma

    J. M. Vose;B. K. Link;M. L. Grossbard;M. Czuczman

  • Standard-of-Care Axicabtagene Ciloleucel for Relapsed or Refractory Large B-Cell Lymphoma: Results From the US Lymphoma CAR T Consortium

    Loretta J. Nastoupil;Michael D. Jain;Lei Feng;Jay Y. Spiegel

Frequent Co-Authors

James O. Armitage
James O. Armitage University of Nebraska Medical Center
Dennis D. Weisenburger
Dennis D. Weisenburger University of Nebraska Medical Center
Ranjana H. Advani
Ranjana H. Advani Stanford University
Randy D. Gascoyne
Randy D. Gascoyne BC Cancer Agency
Wing C. Chan
Wing C. Chan City of Hope
Elaine S. Jaffe
Elaine S. Jaffe National Institutes of Health
Louis M. Staudt
Louis M. Staudt National Institutes of Health
Andrew D. Zelenetz
Andrew D. Zelenetz Memorial Sloan Kettering Cancer Center
Andreas Rosenwald
Andreas Rosenwald University of Würzburg
Nancy L. Bartlett
Nancy L. Bartlett Washington University in St. Louis

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in a flexible path towards a healthcare career in the USA, online medical degrees offer a variety of options to suit different needs and schedules. Busy professionals and aspiring medical workers can now upskill or change their career trajectory without sacrificing their current commitments.

Pursuing rn bsn online programs no clinicals allows registered nurses to earn their Bachelor of Science in Nursing fully online, without the traditional in-person clinical requirements. This option enables faster completion for those with existing experience.

Medical professionals seeking advanced practice roles should consider short dnp programs or even a 1 year dnp program online. These streamlined doctorate programs help nurses achieve leadership or specialist positions in less time.

For those aiming to quickly enter the healthcare workforce, there are also fast track medical programs. These options are ideal for students who want to become Licensed Practical Nurses and start serving patients sooner.

With more accredited, high-quality online programs available than ever, students can find pathways that fit their personal and professional goals while meeting licensure requirements.

Best Scientists Citing Julie M. Vose

Trending Scientists

Recently Published Articles